---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-007933"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T07:13:50.344298+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical amends bylaws to set quorum at 1/3 of outstanding shares

## Summary
- Amendment changes shareholder meeting quorum from previous level to 1/3 of shares outstanding as of record date.
- Board of Directors approved the bylaw amendment on February 14, 2025.
- Effective as of February 14, 2025; no other changes to bylaws disclosed.
- Company remains an emerging growth company under SEC rules.

## SEC filing metadata
- accession: 0001493152-25-007933
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/0001493152-25-007933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-007933
- JSON: https://secwatch.observer/filing/0001493152-25-007933.json
- Plain text: https://secwatch.observer/filing/0001493152-25-007933.txt

## Key facts
- Governance Changes
  Ocean Biomedical, Inc.: On February 14, 2025, Ocean Biomedical, Inc. amended its Bylaws to change the quorum for shareholders meetings to 1/3 of the shares of common stock outstanding on the record date for such meeting (effective 2025-02-14).
  - Change: bylaw amendment
  - Effective: 2025-02-14
  source text: On February 14, 2025, Ocean Biomedical, Inc. (the "Company") amended its Bylaws to change the quorum for shareholders meetings to 1/3 of the shares of common stock outstanding on the record date for such meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/0001493152-25-007933-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
